nodes	percent_of_prediction	percent_of_DWPC	metapath
Colistimethate—Immune system disorder—Thiotepa—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Colistimethate—Dysphonia—Doxorubicin—urinary bladder cancer	0.00404	0.00404	CcSEcCtD
Colistimethate—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.00403	0.00403	CcSEcCtD
Colistimethate—Vomiting—Mitomycin—urinary bladder cancer	0.00402	0.00402	CcSEcCtD
Colistimethate—Rash—Mitomycin—urinary bladder cancer	0.00399	0.00399	CcSEcCtD
Colistimethate—Dermatitis—Mitomycin—urinary bladder cancer	0.00398	0.00398	CcSEcCtD
Colistimethate—Headache—Mitomycin—urinary bladder cancer	0.00396	0.00396	CcSEcCtD
Colistimethate—Bronchospasm—Etoposide—urinary bladder cancer	0.00395	0.00395	CcSEcCtD
Colistimethate—Mental disorder—Thiotepa—urinary bladder cancer	0.00392	0.00392	CcSEcCtD
Colistimethate—Malnutrition—Thiotepa—urinary bladder cancer	0.0039	0.0039	CcSEcCtD
Colistimethate—Oliguria—Epirubicin—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Colistimethate—Epistaxis—Fluorouracil—urinary bladder cancer	0.00389	0.00389	CcSEcCtD
Colistimethate—Dysarthria—Epirubicin—urinary bladder cancer	0.00379	0.00379	CcSEcCtD
Colistimethate—Creatinine increased—Epirubicin—urinary bladder cancer	0.00377	0.00377	CcSEcCtD
Colistimethate—Nausea—Mitomycin—urinary bladder cancer	0.00375	0.00375	CcSEcCtD
Colistimethate—Urinary tract disorder—Gemcitabine—urinary bladder cancer	0.00372	0.00372	CcSEcCtD
Colistimethate—Connective tissue disorder—Gemcitabine—urinary bladder cancer	0.0037	0.0037	CcSEcCtD
Colistimethate—Urethral disorder—Gemcitabine—urinary bladder cancer	0.00369	0.00369	CcSEcCtD
Colistimethate—Oliguria—Doxorubicin—urinary bladder cancer	0.0036	0.0036	CcSEcCtD
Colistimethate—Dysarthria—Doxorubicin—urinary bladder cancer	0.00351	0.00351	CcSEcCtD
Colistimethate—Creatinine increased—Doxorubicin—urinary bladder cancer	0.00349	0.00349	CcSEcCtD
Colistimethate—Salivary hypersecretion—Epirubicin—urinary bladder cancer	0.00348	0.00348	CcSEcCtD
Colistimethate—Urinary tract disorder—Cisplatin—urinary bladder cancer	0.00346	0.00346	CcSEcCtD
Colistimethate—Connective tissue disorder—Cisplatin—urinary bladder cancer	0.00345	0.00345	CcSEcCtD
Colistimethate—Urethral disorder—Cisplatin—urinary bladder cancer	0.00344	0.00344	CcSEcCtD
Colistimethate—Candida infection—Epirubicin—urinary bladder cancer	0.00343	0.00343	CcSEcCtD
Colistimethate—Immune system disorder—Gemcitabine—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Colistimethate—Cough—Thiotepa—urinary bladder cancer	0.0034	0.0034	CcSEcCtD
Colistimethate—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Colistimethate—Blood urea increased—Epirubicin—urinary bladder cancer	0.00339	0.00339	CcSEcCtD
Colistimethate—Convulsion—Thiotepa—urinary bladder cancer	0.00338	0.00338	CcSEcCtD
Colistimethate—Arthralgia—Thiotepa—urinary bladder cancer	0.00332	0.00332	CcSEcCtD
Colistimethate—Anxiety—Thiotepa—urinary bladder cancer	0.0033	0.0033	CcSEcCtD
Colistimethate—Tinnitus—Cisplatin—urinary bladder cancer	0.00327	0.00327	CcSEcCtD
Colistimethate—Salivary hypersecretion—Doxorubicin—urinary bladder cancer	0.00322	0.00322	CcSEcCtD
Colistimethate—Urinary tract disorder—Etoposide—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Colistimethate—Candida infection—Doxorubicin—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Colistimethate—Immune system disorder—Cisplatin—urinary bladder cancer	0.00317	0.00317	CcSEcCtD
Colistimethate—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00316	0.00316	CcSEcCtD
Colistimethate—Urethral disorder—Etoposide—urinary bladder cancer	0.00315	0.00315	CcSEcCtD
Colistimethate—Blood urea increased—Doxorubicin—urinary bladder cancer	0.00313	0.00313	CcSEcCtD
Colistimethate—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00312	0.00312	CcSEcCtD
Colistimethate—Malnutrition—Cisplatin—urinary bladder cancer	0.00305	0.00305	CcSEcCtD
Colistimethate—Flatulence—Cisplatin—urinary bladder cancer	0.00301	0.00301	CcSEcCtD
Colistimethate—Immune system disorder—Etoposide—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Colistimethate—Mediastinal disorder—Etoposide—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Thiotepa—urinary bladder cancer	0.0029	0.0029	CcSEcCtD
Colistimethate—Cough—Gemcitabine—urinary bladder cancer	0.00286	0.00286	CcSEcCtD
Colistimethate—Paraesthesia—Thiotepa—urinary bladder cancer	0.00285	0.00285	CcSEcCtD
Colistimethate—Somnolence—Thiotepa—urinary bladder cancer	0.00283	0.00283	CcSEcCtD
Colistimethate—Convulsion—Fluorouracil—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Colistimethate—Arthralgia—Gemcitabine—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Colistimethate—Chest pain—Gemcitabine—urinary bladder cancer	0.00279	0.00279	CcSEcCtD
Colistimethate—Decreased appetite—Thiotepa—urinary bladder cancer	0.00276	0.00276	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Chest pain—Fluorouracil—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Fatigue—Thiotepa—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Dysgeusia—Etoposide—urinary bladder cancer	0.00274	0.00274	CcSEcCtD
Colistimethate—Convulsion—Cisplatin—urinary bladder cancer	0.00265	0.00265	CcSEcCtD
Colistimethate—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00262	0.00262	CcSEcCtD
Colistimethate—Anxiety—Cisplatin—urinary bladder cancer	0.00259	0.00259	CcSEcCtD
Colistimethate—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00258	0.00258	CcSEcCtD
Colistimethate—Urticaria—Thiotepa—urinary bladder cancer	0.00253	0.00253	CcSEcCtD
Colistimethate—Vertigo—Etoposide—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Colistimethate—Body temperature increased—Thiotepa—urinary bladder cancer	0.00251	0.00251	CcSEcCtD
Colistimethate—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Colistimethate—Cough—Etoposide—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Colistimethate—Blood creatinine increased—Epirubicin—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Gemcitabine—urinary bladder cancer	0.00244	0.00244	CcSEcCtD
Colistimethate—Convulsion—Etoposide—urinary bladder cancer	0.00242	0.00242	CcSEcCtD
Colistimethate—Asthma—Methotrexate—urinary bladder cancer	0.00241	0.00241	CcSEcCtD
Colistimethate—Paraesthesia—Gemcitabine—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Fluorouracil—urinary bladder cancer	0.0024	0.0024	CcSEcCtD
Colistimethate—Dyspnoea—Gemcitabine—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Colistimethate—Chest pain—Etoposide—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Colistimethate—Somnolence—Gemcitabine—urinary bladder cancer	0.00238	0.00238	CcSEcCtD
Colistimethate—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00236	0.00236	CcSEcCtD
Colistimethate—Dyspnoea—Fluorouracil—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Colistimethate—Hypersensitivity—Thiotepa—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Colistimethate—Somnolence—Fluorouracil—urinary bladder cancer	0.00234	0.00234	CcSEcCtD
Colistimethate—Decreased appetite—Gemcitabine—urinary bladder cancer	0.00232	0.00232	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Colistimethate—Abdominal discomfort—Methotrexate—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Colistimethate—Fatigue—Gemcitabine—urinary bladder cancer	0.00231	0.00231	CcSEcCtD
Colistimethate—Decreased appetite—Fluorouracil—urinary bladder cancer	0.00229	0.00229	CcSEcCtD
Colistimethate—Asthenia—Thiotepa—urinary bladder cancer	0.00228	0.00228	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Cisplatin—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00227	0.00227	CcSEcCtD
Colistimethate—Blood creatinine increased—Doxorubicin—urinary bladder cancer	0.00226	0.00226	CcSEcCtD
Colistimethate—Asthma—Epirubicin—urinary bladder cancer	0.00225	0.00225	CcSEcCtD
Colistimethate—Paraesthesia—Cisplatin—urinary bladder cancer	0.00224	0.00224	CcSEcCtD
Colistimethate—Dyspnoea—Cisplatin—urinary bladder cancer	0.00222	0.00222	CcSEcCtD
Colistimethate—Diarrhoea—Thiotepa—urinary bladder cancer	0.00218	0.00218	CcSEcCtD
Colistimethate—Decreased appetite—Cisplatin—urinary bladder cancer	0.00217	0.00217	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00215	0.00215	CcSEcCtD
Colistimethate—Body temperature increased—Gemcitabine—urinary bladder cancer	0.00211	0.00211	CcSEcCtD
Colistimethate—Dizziness—Thiotepa—urinary bladder cancer	0.0021	0.0021	CcSEcCtD
Colistimethate—Urticaria—Fluorouracil—urinary bladder cancer	0.00209	0.00209	CcSEcCtD
Colistimethate—Asthma—Doxorubicin—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Colistimethate—Body temperature increased—Fluorouracil—urinary bladder cancer	0.00208	0.00208	CcSEcCtD
Colistimethate—Paraesthesia—Etoposide—urinary bladder cancer	0.00205	0.00205	CcSEcCtD
Colistimethate—Dyspnoea—Etoposide—urinary bladder cancer	0.00204	0.00204	CcSEcCtD
Colistimethate—Somnolence—Etoposide—urinary bladder cancer	0.00203	0.00203	CcSEcCtD
Colistimethate—Epistaxis—Methotrexate—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Colistimethate—Vomiting—Thiotepa—urinary bladder cancer	0.00202	0.00202	CcSEcCtD
Colistimethate—Rash—Thiotepa—urinary bladder cancer	0.002	0.002	CcSEcCtD
Colistimethate—Dermatitis—Thiotepa—urinary bladder cancer	0.002	0.002	CcSEcCtD
Colistimethate—Headache—Thiotepa—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Colistimethate—Decreased appetite—Etoposide—urinary bladder cancer	0.00199	0.00199	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Colistimethate—Body temperature increased—Cisplatin—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Colistimethate—Fatigue—Etoposide—urinary bladder cancer	0.00197	0.00197	CcSEcCtD
Colistimethate—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.00194	0.00194	CcSEcCtD
Colistimethate—Asthenia—Gemcitabine—urinary bladder cancer	0.00192	0.00192	CcSEcCtD
Colistimethate—Urinary tract disorder—Methotrexate—urinary bladder cancer	0.0019	0.0019	CcSEcCtD
Colistimethate—Epistaxis—Epirubicin—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Colistimethate—Nausea—Thiotepa—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Colistimethate—Urethral disorder—Methotrexate—urinary bladder cancer	0.00189	0.00189	CcSEcCtD
Colistimethate—Hypersensitivity—Cisplatin—urinary bladder cancer	0.00184	0.00184	CcSEcCtD
Colistimethate—Diarrhoea—Gemcitabine—urinary bladder cancer	0.00183	0.00183	CcSEcCtD
Colistimethate—Urticaria—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Colistimethate—Body temperature increased—Etoposide—urinary bladder cancer	0.00181	0.00181	CcSEcCtD
Colistimethate—Diarrhoea—Fluorouracil—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Colistimethate—Tinnitus—Methotrexate—urinary bladder cancer	0.0018	0.0018	CcSEcCtD
Colistimethate—Asthenia—Cisplatin—urinary bladder cancer	0.00179	0.00179	CcSEcCtD
Colistimethate—Urinary tract disorder—Epirubicin—urinary bladder cancer	0.00178	0.00178	CcSEcCtD
Colistimethate—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Colistimethate—Urethral disorder—Epirubicin—urinary bladder cancer	0.00177	0.00177	CcSEcCtD
Colistimethate—Epistaxis—Doxorubicin—urinary bladder cancer	0.00175	0.00175	CcSEcCtD
Colistimethate—Immune system disorder—Methotrexate—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Colistimethate—Dizziness—Fluorouracil—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Colistimethate—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00174	0.00174	CcSEcCtD
Colistimethate—Diarrhoea—Cisplatin—urinary bladder cancer	0.00171	0.00171	CcSEcCtD
Colistimethate—Vomiting—Gemcitabine—urinary bladder cancer	0.0017	0.0017	CcSEcCtD
Colistimethate—Mental disorder—Methotrexate—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Colistimethate—Rash—Gemcitabine—urinary bladder cancer	0.00169	0.00169	CcSEcCtD
Colistimethate—Dermatitis—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Hypersensitivity—Etoposide—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Tinnitus—Epirubicin—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Malnutrition—Methotrexate—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Headache—Gemcitabine—urinary bladder cancer	0.00168	0.00168	CcSEcCtD
Colistimethate—Vomiting—Fluorouracil—urinary bladder cancer	0.00167	0.00167	CcSEcCtD
Colistimethate—Rash—Fluorouracil—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Colistimethate—Dermatitis—Fluorouracil—urinary bladder cancer	0.00166	0.00166	CcSEcCtD
Colistimethate—Headache—Fluorouracil—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Colistimethate—Urinary tract disorder—Doxorubicin—urinary bladder cancer	0.00165	0.00165	CcSEcCtD
Colistimethate—Dysgeusia—Methotrexate—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Colistimethate—Asthenia—Etoposide—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Colistimethate—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00164	0.00164	CcSEcCtD
Colistimethate—Urethral disorder—Doxorubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Colistimethate—Immune system disorder—Epirubicin—urinary bladder cancer	0.00163	0.00163	CcSEcCtD
Colistimethate—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00162	0.00162	CcSEcCtD
Colistimethate—Nausea—Gemcitabine—urinary bladder cancer	0.00159	0.00159	CcSEcCtD
Colistimethate—Vomiting—Cisplatin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Colistimethate—Mental disorder—Epirubicin—urinary bladder cancer	0.00158	0.00158	CcSEcCtD
Colistimethate—Rash—Cisplatin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Colistimethate—Dermatitis—Cisplatin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Colistimethate—Malnutrition—Epirubicin—urinary bladder cancer	0.00157	0.00157	CcSEcCtD
Colistimethate—Diarrhoea—Etoposide—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Colistimethate—Nausea—Fluorouracil—urinary bladder cancer	0.00156	0.00156	CcSEcCtD
Colistimethate—Tinnitus—Doxorubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Colistimethate—Flatulence—Epirubicin—urinary bladder cancer	0.00155	0.00155	CcSEcCtD
Colistimethate—Dysgeusia—Epirubicin—urinary bladder cancer	0.00154	0.00154	CcSEcCtD
Colistimethate—Dizziness—Etoposide—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Colistimethate—Immune system disorder—Doxorubicin—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Colistimethate—Vertigo—Methotrexate—urinary bladder cancer	0.00151	0.00151	CcSEcCtD
Colistimethate—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.0015	0.0015	CcSEcCtD
Colistimethate—Nausea—Cisplatin—urinary bladder cancer	0.00148	0.00148	CcSEcCtD
Colistimethate—Cough—Methotrexate—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Colistimethate—Mental disorder—Doxorubicin—urinary bladder cancer	0.00146	0.00146	CcSEcCtD
Colistimethate—Convulsion—Methotrexate—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Vomiting—Etoposide—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Malnutrition—Doxorubicin—urinary bladder cancer	0.00145	0.00145	CcSEcCtD
Colistimethate—Rash—Etoposide—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Colistimethate—Dermatitis—Etoposide—urinary bladder cancer	0.00144	0.00144	CcSEcCtD
Colistimethate—Headache—Etoposide—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Flatulence—Doxorubicin—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Arthralgia—Methotrexate—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Chest pain—Methotrexate—urinary bladder cancer	0.00143	0.00143	CcSEcCtD
Colistimethate—Dysgeusia—Doxorubicin—urinary bladder cancer	0.00142	0.00142	CcSEcCtD
Colistimethate—Vertigo—Epirubicin—urinary bladder cancer	0.00141	0.00141	CcSEcCtD
Colistimethate—Cough—Epirubicin—urinary bladder cancer	0.00137	0.00137	CcSEcCtD
Colistimethate—Convulsion—Epirubicin—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Nausea—Etoposide—urinary bladder cancer	0.00136	0.00136	CcSEcCtD
Colistimethate—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Chest pain—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Arthralgia—Epirubicin—urinary bladder cancer	0.00134	0.00134	CcSEcCtD
Colistimethate—Anxiety—Epirubicin—urinary bladder cancer	0.00133	0.00133	CcSEcCtD
Colistimethate—Vertigo—Doxorubicin—urinary bladder cancer	0.0013	0.0013	CcSEcCtD
Colistimethate—Cough—Doxorubicin—urinary bladder cancer	0.00127	0.00127	CcSEcCtD
Colistimethate—Convulsion—Doxorubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00126	0.00126	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.00125	0.00125	CcSEcCtD
Colistimethate—Arthralgia—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Colistimethate—Chest pain—Doxorubicin—urinary bladder cancer	0.00124	0.00124	CcSEcCtD
Colistimethate—Anxiety—Doxorubicin—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Colistimethate—Paraesthesia—Methotrexate—urinary bladder cancer	0.00123	0.00123	CcSEcCtD
Colistimethate—Dyspnoea—Methotrexate—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Colistimethate—Somnolence—Methotrexate—urinary bladder cancer	0.00122	0.00122	CcSEcCtD
Colistimethate—Decreased appetite—Methotrexate—urinary bladder cancer	0.00119	0.00119	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Colistimethate—Fatigue—Methotrexate—urinary bladder cancer	0.00118	0.00118	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.00117	0.00117	CcSEcCtD
Colistimethate—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00116	0.00116	CcSEcCtD
Colistimethate—Paraesthesia—Epirubicin—urinary bladder cancer	0.00115	0.00115	CcSEcCtD
Colistimethate—Dyspnoea—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Colistimethate—Somnolence—Epirubicin—urinary bladder cancer	0.00114	0.00114	CcSEcCtD
Colistimethate—Decreased appetite—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00111	0.00111	CcSEcCtD
Colistimethate—Fatigue—Epirubicin—urinary bladder cancer	0.0011	0.0011	CcSEcCtD
Colistimethate—Urticaria—Methotrexate—urinary bladder cancer	0.00109	0.00109	CcSEcCtD
Colistimethate—Body temperature increased—Methotrexate—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.00108	0.00108	CcSEcCtD
Colistimethate—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Dyspnoea—Doxorubicin—urinary bladder cancer	0.00106	0.00106	CcSEcCtD
Colistimethate—Somnolence—Doxorubicin—urinary bladder cancer	0.00105	0.00105	CcSEcCtD
Colistimethate—Decreased appetite—Doxorubicin—urinary bladder cancer	0.00103	0.00103	CcSEcCtD
Colistimethate—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Fatigue—Doxorubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Urticaria—Epirubicin—urinary bladder cancer	0.00102	0.00102	CcSEcCtD
Colistimethate—Body temperature increased—Epirubicin—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Hypersensitivity—Methotrexate—urinary bladder cancer	0.00101	0.00101	CcSEcCtD
Colistimethate—Asthenia—Methotrexate—urinary bladder cancer	0.000981	0.000981	CcSEcCtD
Colistimethate—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000943	0.000943	CcSEcCtD
Colistimethate—Urticaria—Doxorubicin—urinary bladder cancer	0.000941	0.000941	CcSEcCtD
Colistimethate—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Colistimethate—Diarrhoea—Methotrexate—urinary bladder cancer	0.000936	0.000936	CcSEcCtD
Colistimethate—Asthenia—Epirubicin—urinary bladder cancer	0.000918	0.000918	CcSEcCtD
Colistimethate—Dizziness—Methotrexate—urinary bladder cancer	0.000905	0.000905	CcSEcCtD
Colistimethate—Diarrhoea—Epirubicin—urinary bladder cancer	0.000876	0.000876	CcSEcCtD
Colistimethate—Hypersensitivity—Doxorubicin—urinary bladder cancer	0.000873	0.000873	CcSEcCtD
Colistimethate—Vomiting—Methotrexate—urinary bladder cancer	0.00087	0.00087	CcSEcCtD
Colistimethate—Rash—Methotrexate—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Colistimethate—Dermatitis—Methotrexate—urinary bladder cancer	0.000862	0.000862	CcSEcCtD
Colistimethate—Headache—Methotrexate—urinary bladder cancer	0.000857	0.000857	CcSEcCtD
Colistimethate—Asthenia—Doxorubicin—urinary bladder cancer	0.00085	0.00085	CcSEcCtD
Colistimethate—Dizziness—Epirubicin—urinary bladder cancer	0.000846	0.000846	CcSEcCtD
Colistimethate—Vomiting—Epirubicin—urinary bladder cancer	0.000814	0.000814	CcSEcCtD
Colistimethate—Nausea—Methotrexate—urinary bladder cancer	0.000812	0.000812	CcSEcCtD
Colistimethate—Diarrhoea—Doxorubicin—urinary bladder cancer	0.00081	0.00081	CcSEcCtD
Colistimethate—Rash—Epirubicin—urinary bladder cancer	0.000807	0.000807	CcSEcCtD
Colistimethate—Dermatitis—Epirubicin—urinary bladder cancer	0.000806	0.000806	CcSEcCtD
Colistimethate—Headache—Epirubicin—urinary bladder cancer	0.000802	0.000802	CcSEcCtD
Colistimethate—Dizziness—Doxorubicin—urinary bladder cancer	0.000783	0.000783	CcSEcCtD
Colistimethate—Nausea—Epirubicin—urinary bladder cancer	0.00076	0.00076	CcSEcCtD
Colistimethate—Vomiting—Doxorubicin—urinary bladder cancer	0.000753	0.000753	CcSEcCtD
Colistimethate—Rash—Doxorubicin—urinary bladder cancer	0.000747	0.000747	CcSEcCtD
Colistimethate—Dermatitis—Doxorubicin—urinary bladder cancer	0.000746	0.000746	CcSEcCtD
Colistimethate—Headache—Doxorubicin—urinary bladder cancer	0.000742	0.000742	CcSEcCtD
Colistimethate—Nausea—Doxorubicin—urinary bladder cancer	0.000704	0.000704	CcSEcCtD
